Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 ) - Olema Pharmaceuticals ( NASDAQ:OLMA )
SAN FRANCISCO, June 03, 2025 ( GLOBE NEWSWIRE ) -- Olema Pharmaceuticals, Inc. ( ( "Olema" or "Olema Oncology", NASDAQ:OLMA ) , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today ...
Beyond Oil Issues Clarification Regarding Previous German-Language Media Activities
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, June 03, 2025 ( GLOBE NEWSWIRE ) -- As a result of a review by the British Columbia Securities Commission ( the "BCSC" ) , Beyond Oil Ltd. ( CSE: BOIL. OTCQB: BEOLF. Frankfurt: UH9 ) ( "Beyond Oil" or the "Company" ) today issued the following press ...
Ingersoll Rand to Participate in Upcoming Investor Conference
DAVIDSON, N.C., June 03, 2025 ( GLOBE NEWSWIRE ) -- Ingersoll Rand Inc. ( NYSE: IR ) , a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, and Matthew Fort, vice president, Investor Relations and FP&A, ...
Outset Medical Appoints Renee Gaeta as Chief Financial Officer - Outset Medical ( NASDAQ:OM )
SAN JOSE, Calif., June 03, 2025 ( GLOBE NEWSWIRE ) -- Outset Medical, Inc. OM ( "Outset" ) , a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of Renee Gaeta as Chief Financial Officer ( CFO ) , ...
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
WALTHAM, Mass., June 03, 2025 ( GLOBE NEWSWIRE ) -- Xilio Therapeutics, Inc. ( Nasdaq: XLO ) , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective June 1, 2025, the company ...
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
ROCKVILLE, MD, June 03, 2025 ( GLOBE NEWSWIRE ) -- MacroGenics, Inc. ( Nasdaq: MGNX ) , a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that members of the ...
Western New England Bancorp, Inc. Announces Completion of 2024 Repurchase Plan
WESTFIELD, Mass., June 03, 2025 ( GLOBE NEWSWIRE ) -- Western New England Bancorp, Inc. ( the "Company" or "WNEB" ) ( NasdaqGS: WNEB ) , the holding company for Westfield Bank ( the "Bank" ) , announced that on May 30, 2025, the Company completed all repurchases under its existing stock ...
HeartCore Signs 15th Go IPO Contract
NEW YORK and TOKYO, June 03, 2025 ( GLOBE NEWSWIRE ) -- HeartCore Enterprises, Inc. ( Nasdaq: HTCR ) ( "HeartCore" or the "Company" ) , a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement ( "Consulting Agreement" ) with ...
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
SAN FRANCISCO, June 03, 2025 ( GLOBE NEWSWIRE ) -- Olema Pharmaceuticals, Inc. ( "Olema" or "Olema Oncology", Nasdaq: OLMA ) , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today ...
HeartCore Signs 15th Go IPO Contract - HeartCore Enterprises ( NASDAQ:HTCR )
NEW YORK and TOKYO, June 03, 2025 ( GLOBE NEWSWIRE ) -- HeartCore Enterprises, Inc. HTCR ( "HeartCore" or the "Company" ) , a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement ( "Consulting Agreement" ) with tmsuk Co. Ltd. ( ...





